HarborSite is a startup based in the United States.
HarborSite develops a programmable site-specific recombinase platform for precise and efficient therapeutic gene insertion into safe genomic locations, enabling potential one-time treatments for genetic and age-related diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.